AstraZeneca continued to see strong growth in 2024 on the back of a series of positive trials, as well as a solid pipeline of products. View on euronews ...

TD Cowen analyst Steve Scala maintained a Buy rating on AstraZeneca (AZN – Research Report) today. The company’s shares closed yesterday at ...

Sees FY25 revenue up high single-digit percentage. Sees FY25 tax rate 18%-22%. The company said, “The Company is unable to provide guidance on ...

It combines a 1440p resolution with a refresh rate up to 180Hz, ensuring your games look and play their best. Whatever your needs, you’ll find a monitor that meets them in the guide below.

First approval in the US for AstraZeneca and Daiichi Sankyo's Datroway ... 1 While survival rates are high for those diagnosed with early breast cancer, only about 30% of patients diagnosed ...

AstraZeneca Stock Up 2.0 % NASDAQ:AZN opened at $67.96 on Wednesday. AstraZeneca PLC has a twelve month low of $60.47 and a twelve month high of $87.68. The firm has a market capitalization of ...

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be ...

Today, a brief rundown of news involving Novo Nordisk and AstraZeneca, as well as updates from Amgen, Atara Biotherapeutics and Boehringer Ingelheim that you may have missed.

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Every pair of the best over-ear headphones in this guide has been thoroughly tested by our ...

Thought LeaderMina MakarSenior Vice President, Global CVRMAstraZeneca NewsMedical spoke with Mina Makar, Senior Vice President of Global CVRM at AstraZeneca, about groundbreaking research in Heart ...